Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
PUT
Clorox
CLX
$12.7B
| $35.4M | 0.01% |
218,000
-51,900
| -19% | -$8.49M |
|
1577
CALL
Prologis
PLD
$134B
| $35.4M | 0.01% |
334,900
-110,300
| -25% | -$12.7M |
|
1578
Broadridge
BR
$19.5B
| $35.3M | 0.01% |
156,155
+104,218
| +201% | +$23.3M |
|
1579
PUT
Rigetti Computing
RGTI
$6.34B
| $35.3M | 0.01% |
2,313,200
+2,283,200
| +7,611% | +$8.52M |
|
1580
Remitly
RELY
$5.51B
| $35.3M | 0.01% |
1,562,323
+1,339,039
| +600% | +$24.6M |
|
1581
STMicroelectronics
STM
$48.5B
| $35.2M | 0.01% |
1,408,911
+361,518
| +35% | +$9.6M |
|
1582
Braze
BRZE
$3.29B
| $35.1M | 0.01% |
839,001
+690,767
| +466% | +$25.1M |
|
1583
CALL
PACCAR
PCAR
$68.9B
| $35.1M | 0.01% |
337,500
-91,000
| -21% | -$9.96M |
|
1584
Cheniere Energy
LNG
$56.1B
| $35M | 0.01% |
162,887
-49,640
| -23% | -$10.1M |
|
1585
PUT
KB Home
KBH
$3.44B
| $34.8M | 0.01% |
529,800
-91,000
| -15% | -$7.08M |
|
1586
Alignment Healthcare
ALHC
$2.91B
| $34.7M | 0.01% |
+3,088,765
| New | +$36.1M |
|
1587
Helmerich & Payne
HP
$4.44B
| $34.7M | 0.01% |
1,084,293
+417,457
| +63% | +$14.2M |
|
1588
Brixmor Property Group
BRX
$9.21B
| $34.7M | 0.01% |
1,244,966
-1,855,030
| -60% | -$52.6M |
|
1589
CRISPR Therapeutics
CRSP
$5.14B
| $34.6M | 0.01% |
878,896
+360,349
| +69% | +$17M |
|
1590
Kinross Gold
KGC
$32.4B
| $34.6M | 0.01% |
3,728,754
+594,145
| +19% | +$5.86M |
|
1591
Alpha Metallurgical Resources
AMR
$2.08B
| $34.5M | 0.01% |
172,575
+42,816
| +33% | +$9.59M |
|
1592
CALL
APA Corp
APA
$14.2B
| $34.5M | 0.01% |
1,495,408
+65,920
| +5% | +$1.54M |
|
1593
Valley National Bancorp
VLY
$8.28B
| $34.5M | 0.01% |
3,803,797
+3,643,000
| +2,266% | +$35.3M |
|
1594
BridgeBio Pharma
BBIO
$15.7B
| $34.4M | 0.01% |
1,255,361
-1,686,753
| -57% | -$43.6M |
|
1595
Allegro MicroSystems
ALGM
$8.21B
| $34.4M | 0.01% |
1,575,442
+235,410
| +18% | +$5.01M |
|
1596
PUT
Stryker
SYK
$130B
| $34.4M | 0.01% |
95,500
-119,800
| -56% | -$44.4M |
|
1597
PUT
Oneok
OKE
$59.6B
| $34.4M | 0.01% |
342,472
-45,802
| -12% | -$4.69M |
|
1598
Semtech
SMTC
$12.9B
| $34.4M | 0.01% |
555,583
+182,186
| +49% | +$9.62M |
|
1599
CALL
Novartis
NVS
$287B
| $34.4M | 0.01% |
353,100
-42,500
| -11% | -$4.53M |
|
1600
CALL
Deckers Outdoor
DECK
$12.7B
| $34.3M | 0.01% |
168,900
-148,700
| -47% | -$26.9M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.